Entity
  • smartbax

    Created in 2021
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    553
  • Activities

  • Technologies

  • Entity types

  • Location

    Leopoldstraße 37, 80802 München, Germany

    München

    Germany

  • Employees

    Scale: 2-10

    Estimated: 4

  • Engaged corporates

    2
    0 2
  • Added in Motherbase

    1 year, 8 months ago
Description
  • Value proposition

    Developing novel multi-targeted antibiotics with extraordinary potency against multi-drug resistant bacteria.

    smartbax develops novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. With the first-in-class compounds, the company targets the multi-drug resistant pathogens methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).

  • smartbax

    We develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms.

  • https://www.smartbax.de/
Corporate interactions BETA
Corporate TypeTweets Articles
HTGF | High-Tech Gründerfonds
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals
HTGF | High-Tech Gründerfonds
Venture Capital and Private Equity Principals
Other

23 May 2023


Boehringer Ingelheim
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Other

23 May 2023


Similar entities
Loading...
Loading...
Social network dynamics